Report ID: 10070542 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Gene Therapy Market Highlights Over 2022 - 2031
The global gene therapy market is estimated to garner around USD 6 billion in revenue by 2031 by growing at a CAGR of nearly 34% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the increasing prevalence of cancer cases, and the ethical acceptance of gene therapy for cancer treatment. For instance, according to the World Cancer Research Fund, cancer cases all over the world were estimated to be 18.1 million in 2020, out of which, 9.3 million cases were in men and 8.8 million in women. Gene therapies are promising therapies applicable to a wide range of diseases, their aim is to radically treat the causes of the diseases instead of only relieving the symptoms.
CLICK TO DOWNLOAD A SAMPLE REPORT
Additionally, rising awareness regarding the benefits of using gene therapy as compared to traditional therapy for the treatment of various diseases, and government support to promote gene therapy-related research are also the major factors that are projected to boost the growth of the gene therapy market.
The COVID-19 had a positive effect on the gene therapy market on the back of extensive utilization of gene technology in the development of vaccines used to treat COVID-19.
However, high operational costs associated with gene therapy and unwanted immune responses are expected to hamper the growth of the gene therapy market.
The market is segmented by indication into cancer, metabolic disorders, eye disorders, cardiovascular diseases, and others, out of which, the cancer segment is anticipated to hold the major share over the forecast period. The growth can be attributed to the increasing prevalence of cancer cases. Several types of cancers, such as brain, lung, breast, pancreatic, liver, prostate, bladder, head and neck, skin, and ovarian cancers are treated with the help of gene therapies. For instance, according to the World Cancer Research Fund, the most common cancers worldwide are breast and lung cancers, contributing 12.5% and 12.2%, respectively, of the total number of new cases diagnosed in 2020.
Global Gene Therapy Market Regional Synopsis
Regionally, the global gene therapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America region is estimated to witness significant growth over the forecast period on the back of rapidly growing cancer cases, presence of high disposable income, and increase in funding for R&D activities related with gene therapy. For instance, according to the Cancer Facts & Figures 2021 report, the estimated number of new cancer cases diagnosed in the United States were 1.9 million in 2021.
On the other hand, Asia-Pacific is expected to witness the highest CAGR during the forecast period owing to the rising number of people prone to various chronic diseases, and increasing approval & launch of gene therapy products. Moreover, an increase in a government initiative to improve healthcare infrastructure, and a rise in healthcare expenditure is predicted to also boost the market growth of the region.
Market Segmentation
Our in-depth analysis of the global gene therapy market includes the following segments:
By Indication
-
Cancer
-
Metabolic Disorders
-
Eye Disorders
-
Cardiovascular Diseases
-
Others
By Technology
-
Adeno Virus Vector
-
Adeno-associated Virus Vector
-
Lentiviral Vector
-
Retroviral Vector
-
Herpes Virus Vector
-
Others
By Application
-
Clinical
-
Commercial
By End-User
-
Pharma & Biotech
-
Academia
Growth Drivers and Challenges Impacting the Growth of the Global Gene Therapy Market
Growth Drivers
-
Increasing prevalence of cancer cases, and ethical acceptance of gene therapy for cancer treatment
-
Rising awareness regarding benefits of using gene therapy as compared to traditional therapy
Challenges
-
High operational costs associated with gene therapy
-
Unwanted immune responses
Key Companies Dominating the Global Gene Therapy Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global gene therapy market that are included in our report are Kineta, Inc., Novartis AG, Amgen Inc., bluebird bio, Inc., Gilead Sciences, Inc., Orchard Therapeutics plc, SIBIONO, Questex, CRISPR Therapeutics, Editas Medicine, and others.
Latest Developments in the Global Gene Therapy Market:
-
December 2018: Kineta Immuno-Oncology, LLC, a subsidiary of Kineta, Inc., announced its strategic research collaboration and license agreement with Pfizer Inc. to expand RIG-I agonist immunotherapies for the cancer treatment.
-
May 2019: AveXis, a subsidiary of Novartis AG, announced the approval of Zolgensma (onasemnogene abeparvovec-xioi) by the U.S. Food and Drug Administration (FDA), to cure pediatric patients younger than 2 years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Frequently Asked Question
The market is segmented by indication, technology, application, end user, and by region.
The cancer segment is anticipated to hold largest market size in value and display significant growth opportunities.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10070542 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
